Skip to NavigationSkip to content

Pharmafile - Sales and Marketing

Keytruda overtakes Opdivo to lead sales in global immune checkpoint inhibitor market, report reveals
MSD’s Keytruda (pembrolizumab) overtook Bristol-Myers Squibb’s (BMS) blockbuster drug Opdivo (nivolumab) in total sales in the third quarter of...
Alkermes snaps up Rodin Therapeutics for a potential $950 million
Through the deal, Alkermes intends to push “Investigational New Drug (IND)-enabling activities” for Rodin’s preclinical products in the treatment...
Pfizer's Humira biosimilar secures FDA approval, due to launch in 2023
Pfizer has confirmed the FDA approval of Abrilada (adalimumab-afzb),  its biosimilar version of AbbVie’s Humira, the world’s best-selling drug...
EMA advisory panel recommends Mayzent for secondary progressive multiple sclerosis
Novartis has revealed that Mayzent has been recommended by the EMA's CHMP for the treatment of secondary progressive multiple sclerosis (SPMS),...
>> More Sales and Marketing News Stories

Features

Bringing the clinical trial home

Clinical trials are the backbone of healthcare and drug research, but many key patient populations have in the past been unable to take part in...

>> More Features

Appointments

Gilead appoints Andrew Dickinson as CFO

Gilead Sciences have announced that Andrew Dickinson has been appointed as Chief Financial Officer (CFO) effective 1 November.

Dickinson...

For more appointments click here

Mission Statement
Pharmafile.com is a leading portal for the pharmaceutical industry, providing industry professionals with pharma news, pharma events, pharma service company listings and pharma jobs,
Site content is produced by our editorial team exclusively for Pharmafile.com and our industry newspaper Pharmafocus. Service company profiles and listings are taken from our pharmaceutical industry directory, Pharmafile, and presented in a unique Find and Compare format to ensure the most relevant matches